| Year |
Citation |
Score |
| 2020 |
Brunner HI, Quartier P, Alexeeva E, Constantin T, Koné-Paut I, Marzan K, Schneider R, Wulffraat NM, Chasnyk V, Tirosh I, Kallinich T, Kuemmerle-Deschner J, Wouters C, Lauwerys B, Nikishina I, et al. Efficacy and Safety of Canakinumab in sJIA Patients with and without Fever at Baseline: Results from an Open-label, Active Treatment Extension Study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 32648697 DOI: 10.1002/Art.41436 |
0.333 |
|
| 2019 |
Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, de Boer J, Brumm G, Torrent RB, Constantin T, DeLibero C, Diaz J, Gerloni VM, Guedes M, Heiligenhaus A, et al. Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC). Pediatric Rheumatology Online Journal. 17: 66. PMID 31575380 DOI: 10.1186/S12969-019-0345-2 |
0.317 |
|
| 2019 |
Mallalieu NL, Wimalasundera S, Hsu JC, Douglass W, Wells C, Penades IC, Cuttica R, Huppertz HI, Joos R, Kimura Y, Milojevic D, Rosenkranz M, Schikler K, Constantin T, Wouters C. Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial. Pediatric Rheumatology Online Journal. 17: 57. PMID 31438986 DOI: 10.1186/S12969-019-0364-Z |
0.345 |
|
| 2019 |
Foeldvari I, Constantin T, Vojinović J, Horneff G, Chasnyk V, Dehoorne J, Panaviene V, Sušić G, Stanevicha V, Kobusinska K, Zuber Z, Dobrzyniecka B, Nikishina I, Bader-Meunier B, Breda L, et al. Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial. Arthritis Research & Therapy. 21: 125. PMID 31122296 DOI: 10.1186/S13075-019-1916-9 |
0.384 |
|
| 2019 |
Zulian F, Culpo R, Sperotto F, Anton J, Avcin T, Baildam EM, Boros C, Chaitow J, Constantin T, Kasapcopur O, Knupp Feitosa de Oliveira S, Pilkington CA, Russo R, Toplak N, van Royen A, et al. Consensus-based recommendations for the management of juvenile localised scleroderma. Annals of the Rheumatic Diseases. PMID 30826775 DOI: 10.1136/Annrheumdis-2018-214697 |
0.358 |
|
| 2019 |
Foeldvari I, Torok K, Ambartsumyan L, Anton J, Beyer C, Blakley M, Constantin T, Reis PC, Curran M, Cutolo M, Galdo FD, Denton C, Fligelstone K, Hinrichs B, Höger A, et al. Ab0966 Proposal Of Outcome Measures To Be Used On A 12-Month Open Label Drug Trial In Juvenile Systemic Sclerosis. Results Of The 3Rd Consensus Meeting In Hamburg December 2018 Annals of the Rheumatic Diseases. 78: 1949-1949. DOI: 10.1136/Annrheumdis-2019-Eular.3198 |
0.329 |
|
| 2019 |
Krol R, Swart JF, Giancane G, Roock SD, Herlin T, Dolezalova P, Sanner H, Susic G, Sztajnbok FR, Maritsi D, Constantin T, Vargova V, Sawhney S, Rygg M, Oliveira SKDE, et al. Op0058 Development Of Inflammatory Bowel Disease During Treatment With Etanercept In Patientswith Juvenile Idiopathic Arthritis Annals of the Rheumatic Diseases. 78: 100-101. DOI: 10.1136/Annrheumdis-2019-Eular.3189 |
0.377 |
|
| 2018 |
Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat NM, Horneff G, Kasapcopur O, Schneider R, Anton J, Barash J, Berner R, Corona F, Cuttica R, Fouillet-Desjonqueres M, Fischbach M, et al. Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials. Annals of the Rheumatic Diseases. PMID 30269054 DOI: 10.1136/Annrheumdis-2018-213150 |
0.338 |
|
| 2018 |
Orbán I, Constantin T, Dérfalvi B, Sevcic K, Garan D, Káposzta R, Poór G, Kiss E, Ponyi A, Consolaro A, Bovis F, Ruperto N. The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatology International. 38: 243-250. PMID 29637341 DOI: 10.1007/S00296-018-3955-Y |
0.35 |
|
| 2018 |
Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Annals of the Rheumatic Diseases. PMID 29592918 DOI: 10.1136/Annrheumdis-2018-213131 |
0.354 |
|
| 2018 |
Wimalasundera S, Penades IC, Cuttica R, Huppertz H-, Joos R, Milojevic D, Rosenkranz M, Schikler K, Constantin T, Douglass W, Wells C, Kimura Y, Wouters C. THU0598 Safety of tocilizumab in patients aged <2 years with active systemic juvenile idiopathic arthritis treated for one year Annals of the Rheumatic Diseases. 77: 499-499. DOI: 10.1136/Annrheumdis-2018-Eular.2628 |
0.318 |
|
| 2017 |
Rider LG, Aggarwal R, Pistorio A, Bayat N, Erman B, Feldman BM, Huber AM, Cimaz R, Cuttica RJ, de Oliveira SK, Lindsley CB, Pilkington CA, Punaro M, Ravelli A, Reed AM, ... ... Constantin T, et al. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Annals of the Rheumatic Diseases. 76: 782-791. PMID 28385804 DOI: 10.1136/Annrheumdis-2017-211401 |
0.31 |
|
| 2017 |
Mallalieu N, Hsu J, Wang K, Wimalasundera S, Wells C, Penades IC, Cuttica R, Huppertz H, Joos R, Kimura Y, Milojevic D, Rosenkranz M, Schikler K, Constantin T, Wouters C. OP0197 Evaluation of a dosing regimen for tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2017-Eular.2386 |
0.315 |
|
| 2016 |
Enders FB, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, Lahdenne P, Magnusson B, Nistala K, Ozen S, Pilkington C, Ravelli A, Russo R, Uziel Y, van Brussel M, et al. Consensus-based recommendations for the management of juvenile dermatomyositis. Annals of the Rheumatic Diseases. PMID 27515057 DOI: 10.1136/Annrheumdis-2016-209247 |
0.333 |
|
| 2016 |
Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I, Akikusa JD, Avcin T, Chaitow J, Koskova E, Lauwerys BR, Calvo Penades I, Flato B, Gamir ML, Huppertz HI, et al. Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis. The Journal of Rheumatology. 43: 816-24. PMID 26932344 DOI: 10.3899/Jrheum.150430 |
0.356 |
|
| 2016 |
Odler B, Cseh Á, Constantin T, Fekete G, Losonczy G, Tamási L, Benke K, Szilveszter B, Müller V. Long time enzyme replacement therapy stabilizes obstructive lung disease and alters peripheral immune cell subsets in Fabry patients. The Clinical Respiratory Journal. PMID 26763180 DOI: 10.1111/Crj.12446 |
0.3 |
|
| 2016 |
Ruperto N, Brunner HI, Quartier P, Constantin T, Alexeeva E, Schneider R, Kone-Paut I, Schikler K, Marzan K, Wulffraat N, Padeh S, Chasnyk V, Wouters C, Kuemmerle-Deschner JB, Kallinich T, et al. THU0215 Long-Term Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis (SJIA): 5-Year Follow-up of An Open-Label Trial Annals of the Rheumatic Diseases. 75: 265-266. DOI: 10.1136/Annrheumdis-2016-Eular.3835 |
0.373 |
|
| 2016 |
Ruperto N, Brunner HI, Quartier P, Constantin T, Alexeeva E, Kone-Paut I, Marzan K, Wulffraat N, Schneider R, Padeh S, Chasnyk V, Wouters C, Kuemmerle-Deschner JB, Kallinich T, Lauwerys B, et al. THU0579 Treating To Target with Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis: Results from The Long-Term Extension The Phase III Pivotal Trial Annals of the Rheumatic Diseases. 75: 401-402. DOI: 10.1136/Annrheumdis-2016-Eular.2658 |
0.336 |
|
| 2015 |
Horneff G, Ruperto N, Brunner H, Quartier P, Constantin T, Alexeeva E, Kone-Paut I, Marzan K, Wulffraat N, Schneider R, Padeh S, Chasnyk V, Wouters C, Deschner JK, Kallinich T, et al. Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever Pediatric Rheumatology. 13. DOI: 10.1186/1546-0096-13-S1-O83 |
0.348 |
|
| 2015 |
Foeldvari I, Györgyi Z, Baildam E, Batu ED, Blakley M, Cakan M, Curran M, Fligelstone K, Mouthon L, Nemcova D, Pilkington C, Ruperto N, Tsinti M, Tsitsami E, Urbanvica K, ... Constantin T, et al. AB0984 Development of a Juvenile Systemic Sclerosis Response Index (JSSRI): Table 1 Annals of the Rheumatic Diseases. 74: 1227-1228. DOI: 10.1136/Annrheumdis-2015-Eular.5924 |
0.302 |
|
| 2015 |
Swart J, Pistorio A, Bovis F, Alekseeva E, Hofer M, Nielsen S, Anton J, Consolaro A, Panaviene V, Stanevicha V, Trachana M, Ailioaie C, Quartier P, Benedetti FD, Tsitsami E, ... ... Constantin T, et al. OP0062 The Addition of One or More Biologics to Methotrexate in Children with Juvenile Idiopathic Arthritis Increases the Incidence of Infections and Serious Adverse Events. The 5882 Pharmachild Cohort Annals of the Rheumatic Diseases. 74: 91-91. DOI: 10.1136/Annrheumdis-2015-Eular.4397 |
0.352 |
|
| 2015 |
Ruperto N, Brunner H, Quartier P, Constantin T, Alexeeva E, Kone-Paut I, Marzan K, Wulffraat N, Schneider R, Padeh S, Chasnyk V, Wouters C, Deschner JK, Kallinich T, Lauwerys B, et al. FRI0496 Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis with and Without Fever Annals of the Rheumatic Diseases. 74: 608-608. DOI: 10.1136/Annrheumdis-2015-Eular.2050 |
0.364 |
|
| 2014 |
Moorthy LN, Roy E, Kurra V, Peterson MG, Hassett AL, Lehman TJ, Scott C, El-Ghoneimy D, Saad S, El Feky R, Al-Mayouf S, Dolezalova P, Malcova H, Herlin T, Nielsen S, ... ... Constantin T, et al. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration. Pediatric Rheumatology Online Journal. 12: 49. PMID 25705138 DOI: 10.1186/1546-0096-12-49 |
0.349 |
|
| 2014 |
Enders FB, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman B, Lahdenne P, Magnusson B, Nistala K, Pilkington C, Ravelli A, Russo R, Brussel Mv, Net Jvd, Wedderburn L, et al. SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile dermatomyositis Pediatric Rheumatology. 12: 89. DOI: 10.1186/1546-0096-12-S1-P89 |
0.339 |
|
| 2014 |
Pain C, Constantin T, Baildem E, Beyer C, Lenhartz H, Blackley M, Nemcova D, Pilkington C, Foeldvari I. Gastrointestinal involvement in juvenile systemic sclerosis: development of recommendations for screening and investigation Pediatric Rheumatology. 12: 52. DOI: 10.1186/1546-0096-12-S1-P52 |
0.334 |
|
| 2014 |
Consolaro A, Dolezalova P, Panaviene V, Christensen AE, Merino R, Constantin T, Martini A, Ravelli A. A multinational study of the epidemiology, treatment and outcome of childhood arthritis (epoca study): preliminary data from 6,940 patients Pediatric Rheumatology. 12: 1-2. DOI: 10.1186/1546-0096-12-S1-O8 |
0.34 |
|
| 2013 |
Constantin T, Pain C, Toplak N, Moll M, Konert I, Piotto D, Ayaz N, Nemkova D, Hoeger P, Cutolo M, Smith V, Foeldvari I. PReS-FINAL-2126: How to follow up children with Raynaud syndrome - recommendations based on the Hamburg consensus meeting 2012 Pediatric Rheumatology. 11: 138. DOI: 10.1186/1546-0096-11-S2-P138 |
0.353 |
|
| 2013 |
Ruperto N, Brunner H, Constantin T, Wulffraat N, Horneff G, Anton J, Berner R, Corona F, Cuttica R, Desjonqueres M, Fischbach M, Alessio M, Chieng A, Emminger W, Haddad E, et al. OP0136 Baseline Characteristics of Patients with Active Systemic JIA Successfully Discontinuing Corticosteroid while Receiving Canakinumab: Secondary Analysis from a Pivotal Phase 3 Trial Annals of the Rheumatic Diseases. 72: A97.3-A98. DOI: 10.1136/Annrheumdis-2013-Eular.341 |
0.337 |
|
| 2013 |
Constantin T, Pain C, Toplak N, Moll M, Iking-Konert C, Piotto D, Aktay N, Nemcova D, Hoeger P, Cutolo M, Smith V, Foeldvari I. SAT0484 Minimum Diagnostic Standards for Children with Raynaud’s Phenomenon - Results of the Consensus Meeting in Hamburg (Germany) on December 9, 2012 Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.2208 |
0.409 |
|
| 2013 |
Quartier P, Erguven M, Horneff G, Berkun Y, Lheritier K, Kim D, Abrams K, Constantin T. AB1186 IL-1beta inhibition with canakinumab in patients with systemic juvenile idiopathic arthritis: Efficacy and safety outcomes from a single-dose, placebo-controlled study Annals of the Rheumatic Diseases. 71: 705-705. DOI: 10.1136/Annrheumdis-2012-Eular.1184 |
0.342 |
|
| 2013 |
Ruperto N, Brunner H, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, et al. AB1182 Efficacy and safety of canakinumab, fully human anti-interleukin-1beta antibody, in systemic juvenile idiopathic arthritis Annals of the Rheumatic Diseases. 71: 705-705. DOI: 10.1136/Annrheumdis-2012-Eular.1180 |
0.319 |
|
| 2012 |
Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. The New England Journal of Medicine. 367: 2396-406. PMID 23252526 DOI: 10.1056/Nejmoa1205099 |
0.35 |
|
| 2011 |
Garan D, Bence Z, Gács Z, Szabó A, Constantin T. ANCA-associated vasculitides in childhood Pediatric Rheumatology. 9: 95. DOI: 10.1186/1546-0096-9-S1-P95 |
0.33 |
|
| 2011 |
Ruperto N, Brunner H, Horneff G, Quartier P, Constantin T, Berkun Y, Erguven M, Kallinich T, Brik R, Wulffraat N, Ferrandiz M, Rutkowska-Sak L, Ozdogan H, McCann L, Lheritier K, et al. Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study Pediatric Rheumatology. 9: 1-2. DOI: 10.1186/1546-0096-9-S1-O21 |
0.316 |
|
| 2010 |
Toplak N, Dolezalovà P, Constantin T, Sedivà A, Paši? S, Cižnar P, Wolska-Ku?nierz B, Harja?ek M, Stefan M, Ruperto N, Gattorno M, Av?in T. Periodic fever syndromes in Eastern and Central European countries: results of a pediatric multinational survey. Pediatric Rheumatology Online Journal. 8: 29. PMID 21539753 DOI: 10.1186/1546-0096-8-29 |
0.315 |
|
| 2010 |
Constantin T, Székely A, Ponyi A, Gulácsy V, Ambrus C, Kádár K, Vastagh I, Dajnoki A, Tóth B, Bokrétás G, Müller V, Katona M, Medvecz M, Fiedler O, Széchey R, et al. Management of Fabry disease | Fabry-betegség - Terápiás útmutató Orvosi Hetilap. 151: 1243-1251. PMID 20656661 DOI: 10.1556/Oh.2010.28796 |
0.354 |
|
| 2010 |
Constantin T, Rákóczi E, Ponyi A, Ambrus C, Kádár K, Vastagh I, Dajnoki A, Tóth B, Bokrétás G, Müller V, Katona M, Csikós M, Fiedler O, Széchey R, Varga E, et al. Fabry disease diagnostic guideline | Fabry-betegség: Diagnosztikai útmutató Orvosi Hetilap. 151: 243-249. PMID 20133243 DOI: 10.1556/Oh.2010.28795 |
0.351 |
|
| 2009 |
Constantin T, Kálovics T, Ponyi A, Nagy E, Sallai K, Szabó L, Garami M, Müller J, Gergely P, Dankó K, Fekete G, Kálmánchey R. Prevalence of antiphospholipid and antinuclear antibodies in children with epilepsy. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 15: CR164-9. PMID 19333200 |
0.522 |
|
| 2007 |
Constantin T, Ponyi A, Kálovics T, Orbán I, Molnár K, Dérfalvy B, Dicso F, Sallai A, Garami M, Balogh Z, Szalai Z, Fekete G, Dankó K. [Disease course, frequency of relapses and survival of patients with juvenile or adult dermatomyositis]. Orvosi Hetilap. 148: 1989-97. PMID 17932005 DOI: 10.1556/Oh.2007.27907 |
0.327 |
|
| 2007 |
Váncsa A, Ponyi A, Constantin T, Zeher M, Dankó K. Pregnancy outcome in idiopathic inflammatory myopathy. Rheumatology International. 27: 435-9. PMID 17033833 DOI: 10.1007/S00296-006-0239-8 |
0.311 |
|
| 2006 |
Constantin T, Ponyi A, Orbán I, Molnár K, Dérfalvi B, Dicso F, Kálovics T, Müller J, Garami M, Sallai A, Balogh Z, Szalai Z, Fekete G, Dankó K. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis. Autoimmunity. 39: 223-32. PMID 16769656 DOI: 10.1080/08916930600622819 |
0.377 |
|
| 2005 |
Ponyi A, Constantin T, Garami M, András C, Tállai B, Váncsa A, Gergely L, Dankó K. Cancer-associated myositis: clinical features and prognostic signs. Annals of the New York Academy of Sciences. 1051: 64-71. PMID 16126945 DOI: 10.1196/Annals.1361.047 |
0.329 |
|
| 2005 |
Müller J, Garami M, Constantin T, Schmidt M, Fekete G, Kovács G. Meropenem in the treatment of febrile neutropenic children. Pediatric Hematology and Oncology. 22: 277-84. PMID 16020114 DOI: 10.1080/08880010590935167 |
0.308 |
|
| 2004 |
Ponyi A, Constantin T, Dankó K. Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlap. Clinical Rheumatology. 23: 371-2. PMID 15293105 DOI: 10.1007/S10067-004-0903-X |
0.33 |
|
| 2004 |
Dankó K, Ponyi A, Constantin T, Borgulya G, Szegedi G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine. 83: 35-42. PMID 14747766 DOI: 10.1097/01.Md.0000109755.65914.5E |
0.315 |
|
| Show low-probability matches. |